OM is a promising CHF drug, provides diversity to AMGN future sales and CYTK has strong fundamentals.
I will also add that AMGN bought over 8 million shares of CYTK for $1.18 it closed today at $1.49. That will help the value of our short term investments on the balance sheet as well. So go ahead give me another thumbs down.
Sentiment: Strong Buy
CYTK in the mid 1.70's now